287 related articles for article (PubMed ID: 28017421)
1. Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases.
Miyazaki D; Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H
Ophthalmology; 2017 Mar; 124(3):287-294. PubMed ID: 28017421
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
Br J Ophthalmol; 2014 Aug; 98(8):1023-7. PubMed ID: 24695688
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
Chatterjee S; Agrawal D
Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
[TBL] [Abstract][Full Text] [Related]
5. Combined therapy for vernal shield ulcer.
Kumar S
Clin Exp Optom; 2008 Jan; 91(1):111-4. PubMed ID: 18045257
[TBL] [Abstract][Full Text] [Related]
6. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
[No Abstract] [Full Text] [Related]
7. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
[TBL] [Abstract][Full Text] [Related]
8. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
Tzu JH; Utine CA; Stern ME; Akpek EK
Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
[TBL] [Abstract][Full Text] [Related]
9. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of allergic conjunctival granuloma by topical tacrolimus: A clinicopathologic case report.
Foroutan A; Ghafourian A; Habibi A; Foroutan P; Ashrafkhorasani M; Alemzadeh SA
Indian J Ophthalmol; 2018 Apr; 66(4):578-580. PubMed ID: 29582827
[TBL] [Abstract][Full Text] [Related]
12. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tacrolimus, fluorometholone, and saline in mild-to-moderate contact lens-induced papillary conjunctivitis.
Diao H; She Z; Cao D; Wang Z; Lin Z
Adv Ther; 2012 Jul; 29(7):645-53. PubMed ID: 22821643
[TBL] [Abstract][Full Text] [Related]
14. Atopic keratoconjunctivitis with corneal ulcer. Case report.
Zemba M; Burcea M; Camburu G
Rom J Ophthalmol; 2016; 60(3):200-206. PubMed ID: 29450349
[No Abstract] [Full Text] [Related]
15. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.
Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM
Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030
[TBL] [Abstract][Full Text] [Related]
16. Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.
Westland T; Patryn EK; Nieuwendaal CP; van der Meulen IJE; Mourits MP; Lapid-Gortzak R
Int Ophthalmol; 2018 Feb; 38(1):363-368. PubMed ID: 28120172
[TBL] [Abstract][Full Text] [Related]
17. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study.
Attas-Fox L; Barkana Y; Iskhakov V; Rayvich S; Gerber Y; Morad Y; Avni I; Zadok D
Curr Eye Res; 2008 Jul; 33(7):545-9. PubMed ID: 18600486
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
Wan Q; Tang J; Han Y; Wang D; Ye H
Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
[TBL] [Abstract][Full Text] [Related]
20. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
